National and Kapodistrian University of Athens
Genomic analysis of systemic lupus erythematosus: molecular mechanisms for tissue injury and response
Abstract
dc:descriptionSystemic lupus erythematosus (SLE) is a heterogenous autoimmune and potentially severe disease. In SLE, an interplay between environmental and genetic factors leads to perturbation of complex biological networks that culminate in immune dysregulation and diverse clinical phenotypes. B cells are the main orchestrators of autoimmune responses in patients with SLE. However broad-based B-cell directed therapies show modest efficacy, while blunting humoral immune responses to vaccines and inducing immunosuppression, underscoring the need for development of more effective therapies targeting the pathogenic B-cell clones. Under steady state, B cells are prone to enriched DNA damage response (DDR) since DDR is co-opted in antibody diversification. Although patients with SLE demonstrate increased levels of DNA damage in genes required for efficient DDR, the role of the DDR in B-cells pathogenicity remains elusive. Furthermore, analysis in disease-involved tissues such as lesional skin indicated higher levels of DNA damage when compared to non-lesional or healthy skin. To this end, our transcriptomic analysis in whole blood cells of patients with SLE compared to healthy subjects, highlights the aberrant expression profile of DDR pathways. This was associated via microscopy studies with enhanced DDR in peripheral B cells of both patients with SLE and murine SLE model. In this direction, utilizing transcriptomic, proteomic and immunofluorescence studies, this thesis provides evidence for enhanced activation of the ATR/Chk1 DDR pathway in B cells of patients with active SLE disease. Treatment of B cells with type I IFN, a key driver of immunity in SLE, induced expression of ATR via direct binding of interferon regulatory factor 1 (IRF1) to its gene promoter. Pharmacologic targeting of ATR in B cells attenuated their immunogenic profile, including proinflammatory cytokine secretion, plasmablast formation and antibody production. Together, these findings identify the ATR-mediated DDR axis as the orchestrator of the type-I IFN-mediated B cell responses in SLE and as a potential novel therapeutic target.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2022
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Manolakou, Theodora
- Μανωλάκου, Θεοδώρα
Subjects
dc:subject × 14Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/52691